These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20415855)

  • 21. [Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].
    Burcelin R; Chabo C; Blasco-Baque V; Sérino M; Amar J
    Med Sci (Paris); 2013; 29(8-9):800-6. PubMed ID: 24005637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metagenome and metabolism: the tissue microbiota hypothesis.
    Burcelin R; Serino M; Chabo C; Garidou L; Pomié C; Courtney M; Amar J; Bouloumié A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():61-70. PubMed ID: 24003922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gut microbiota, responsible for our body weight?].
    Pataky Z; Bobbioni-Harsch E; Hadengue A; Carpentier A; Golay A
    Rev Med Suisse; 2009 Mar; 5(196):662-4, 666. PubMed ID: 19462608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the origin of type 1 diabetes in the gut?
    Vaarala O
    Immunol Cell Biol; 2012 Mar; 90(3):271-6. PubMed ID: 22290506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM; Costa JA; Alfenas RC
    Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
    Musso G; Gambino R; Cassader M
    Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the intestinal microbiota in enteric infection.
    Sekirov I; Finlay BB
    J Physiol; 2009 Sep; 587(Pt 17):4159-67. PubMed ID: 19491248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic interplay between metabolic syndrome and immunity.
    Paragh G; Seres I; Harangi M; Fülöp P
    Adv Exp Med Biol; 2014; 824():171-90. PubMed ID: 25039000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric surgery and the human microbiome.
    Carlisle EM; Morowitz MJ
    J Pediatr Surg; 2011 Mar; 46(3):577-84. PubMed ID: 21376215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A core gut microbiome in obese and lean twins.
    Turnbaugh PJ; Hamady M; Yatsunenko T; Cantarel BL; Duncan A; Ley RE; Sogin ML; Jones WJ; Roe BA; Affourtit JP; Egholm M; Henrissat B; Heath AC; Knight R; Gordon JI
    Nature; 2009 Jan; 457(7228):480-4. PubMed ID: 19043404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters.
    Graessler J; Qin Y; Zhong H; Zhang J; Licinio J; Wong ML; Xu A; Chavakis T; Bornstein AB; Ehrhart-Bornstein M; Lamounier-Zepter V; Lohmann T; Wolf T; Bornstein SR
    Pharmacogenomics J; 2013 Dec; 13(6):514-22. PubMed ID: 23032991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinated regulation of the metabolome and lipidome at the host-microbial interface.
    Bäckhed F; Crawford PA
    Biochim Biophys Acta; 2010 Mar; 1801(3):240-5. PubMed ID: 19782151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, diabetes, and the gut microbiome: an updated review.
    Singer-Englar T; Barlow G; Mathur R
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):3-15. PubMed ID: 30791839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.
    Mai V; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):81-5. PubMed ID: 19115471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.